A Mechanism of Acquiring Temozolomide Resistance During Transformation of Atypical Prolactinoma Into Prolactin-Producing Pituitary Carcinoma: Case Report

O6-methylguanine DNA methyltransferase immunoexpression in nonfunctioning pituitary adenomas

(2009) Georg Widhalm et al.   CANCER

High incidence of low O6-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease

(2009) Akira Takeshita et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy

(2009) C Hagen et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

A novel use of temozolomide in a patient with malignant prolactinoma

(2009) Stephen Byrne et al.   JOURNAL OF CLINICAL NEUROSCIENCE

USE OF TEMOZOLOMIDE IN AGGRESSIVE PITUITARY TUMORS

(2009) Safraz Mohammed et al.   NEUROSURGERY

P53gene mutation in an atypical corticotroph adenoma with Cushing's disease

(2008) Sachiko-Tsukamoto Kawashima et al.   CLINICAL ENDOCRINOLOGY

Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours

(2008) Ann I. McCormack et al.   CLINICAL ENDOCRINOLOGY

Treatment of Nelson's syndrome with temozolomide

(2008) V J Moyes et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Pituitary Carcinoma Presenting with Multiple Metastases: Case Report

(2008) Aslan Guzel et al.   JOURNAL OF CHILD NEUROLOGY